NASDAQ · CANC
Tema Oncology ETF
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
Loading market information…
NASDAQ · SPBC · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Simplify US Equity PLUS Bitcoin Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 4.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Simplify US Equity PLUS Bitcoin Strategy ETF’s forward annual dividend is $0.40 per share, paid quarterly. The forward yield is 0.81% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
SPBC adds Bitcoin exposure to a portfolio of US equities. The fund invests at least 80% of its assets in US equity securities, which include common stocks, preferred stocks, or futures on common or preferred stocks via ETFs and futures. SPBC does not hold physical Bitcoin or invest directly in Bitcoin, Bitcoin futures, or other cryptocurrencies. Instead, the fund aims to allocate 10% of its total assets to exchange-traded products (ETPs) that directly hold spot Bitcoin. The adviser selects Bitcoin ETPs that it believes to offer sufficient liquidity and relatively low expenses. The fund generally rebalances this allocation quarterly but may rebalance more frequently to ensure that Bitcoin exposure does not exceed 25% of its assets. Prior to November 1, 2024, the fund was named Simplify US Equity PLUS GBTC ETF.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:25 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
$75.52-$0.89 (-1.16%)
Calvert US Mid-Cap Core Responsible Index ETF’s quoted price sits in the upper half of its reported 52-week range, 4.37% below the high.
$42.74-$0.89 (-2.04%)
Matthews Asia Innovators Active ETF’s quoted price sits in the lower half of its reported 52-week range, 29.97% below the high.
$126.40-$2.15 (-1.67%)
Invesco S&P Spin-Off ETF’s quoted price sits in the upper half of its reported 52-week range, 15.98% below the high.
$35.19-$0.26 (-0.74%)
Pacer Swan SOS Moderate (January) ETF’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
$41.76-$0.54 (-1.29%)
Overlay Shares Hedged Large Cap Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.29% below the high.
$30.72-$0.15 (-0.47%)
Pacer Swan SOS Conservative (April) ETF’s quoted price sits in the upper half of its reported 52-week range, 0.47% below the high.
$32.82-$0.68 (-2.03%)
THOR Index Rotation ETF’s quoted price sits in the upper half of its reported 52-week range, 6.23% below the high.
